Back
Grupo Financiero Banorte SAB de CV Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
34
GBOOY
Grupo Financiero Banorte SAB de CV
Last Price:
36.22
Seasonality Move:
3.03%
Buy
59
ANIP
ANI Pharmaceuticals
Last Price:
61.42
Seasonality Move:
5.08%
Sell
34
Grupo Financiero Banorte SAB de CV (GBOOY)
is a Sell
Is Grupo Financiero Banorte SAB de CV a Buy, Sell or Hold?
- The current Grupo Financiero Banorte SAB de CV [GBOOY] share price is $36.22. The Score for GBOOY is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- GBOOY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.67. The Score for ANIP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GBOOY Stock Price Chart
What is Grupo Financiero Banorte SAB de CV's stock price today?
-
The Grupo Financiero Banorte SAB de CV share price today is $36.22
The current trend is relatively stagnant and GBOOY is experiencing slight selling pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GBOOY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 49.85 | Sell |
Chaikin Money Flow: | -6878 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.07 - 38.49) | Sell |
Bollinger Bands (100): | (34.95 - 40.09) | Sell |
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 60.46 | Buy |
Chaikin Money Flow: | 225492 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.73 - 59.67) | Buy |
Bollinger Bands (100): | (57.7 - 62.92) | Buy |
GBOOY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.72 | Buy |
20-day SMA: | 36.16 | Buy |
50-day SMA: | 36.23 | Sell |
200-day SMA: | 43.99 | Sell |
8-day EMA: | 36.15 | Buy |
20-day EMA: | 36.18 | Buy |
50-day EMA: | 36.65 | Sell |
200-day EMA: | 40.95 | Sell |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.22 | Buy |
20-day SMA: | 58.64 | Buy |
50-day SMA: | 58.71 | Buy |
200-day SMA: | 62.04 | Sell |
8-day EMA: | 58.8 | Buy |
20-day EMA: | 58.52 | Buy |
50-day EMA: | 58.98 | Buy |
200-day EMA: | 59.88 | Buy |
Grupo Financiero Banorte SAB de CV Earnings Growth & GBOOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.51 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.82 per share.
Grupo Financiero Banorte SAB de CV Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ANI Pharmaceuticals Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |